Ionis Pharmaceuticals (NQ: IONS )
52.78
USD
+1.51
(+2.95%)
Official Closing Price
Updated: 4:29 PM EST, Mar 5, 2021
Add to My Watchlist
All news about Ionis Pharmaceuticals
Ionis establishes new grant program to advance research and understanding of transthyretin amyloidosis
March 01, 2021
From PR Newswire
Ionis Pharmaceuticals, Inc. (IONS) Q4 2020 Earnings Call Transcript
February 24, 2021
From Motley Fool
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
February 24, 2021
From Benzinga
Ionis Pharmaceuticals: Q4 Earnings Insights
February 24, 2021
From Benzinga
Ionis reports fourth quarter and full year 2020 financial results and recent business achievements
February 24, 2021
From PR Newswire
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
From Benzinga
Ionis to present at upcoming investor conferences
February 19, 2021
From PR Newswire
Ionis to hold 2020 financial results webcast
February 11, 2021
From PR Newswire
Tags
Stocks
From Market News Video
From Benzinga
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
January 27, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
January 26, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
From Benzinga
Ionis appoints Eugene Schneider, M.D., as executive vice president and chief clinical development officer
January 07, 2021
From PR Newswire
Ionis to present at 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021
From PR Newswire
From Benzinga
Ionis Pharmaceuticals (IONS) Shares Cross Above 200 DMA
December 18, 2020
Tags
Stocks
From Market News Video
Stanley T. Crooke, Ph.D., M.D, to retire from Ionis to focus on his scientific interests and n-Lorem Foundation
December 17, 2020
From PR Newswire
Ionis highlights achievements, commercial strategy and technology advancements at Investor Day
December 08, 2020
From PR Newswire
Red Clover Market Size, Share, Price, Trends, Growth, Analysis, Key Players, Outlook, Report, Forecast 2020-2025 | ExpertMarketResearch.com
December 04, 2020
From iCrowdNewswire
Ionis to participate in virtual fireside chat at BMO 2020 Growth and ESG conference
December 02, 2020
From PR Newswire
Ionis announces initiation of the global Phase 3 BALANCE study for AKCEA-APOCIII-LRX in patients with familial chylomicronemia syndrome
December 01, 2020
From PR Newswire
Ionis to hold virtual investor day event
December 01, 2020
From PR Newswire
Ionis announces AstraZeneca's initiation of the Phase 2b clinical study of its antisense medicine targeting PCSK9 to lower LDL-cholesterol
November 30, 2020
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.